These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9548508)

  • 1. Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells.
    Cichy J; Rose-John S; Potempa J; Pryjma J; Travis J
    J Immunol; 1997 Dec; 159(11):5648-53. PubMed ID: 9548508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
    Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR
    Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells.
    Holub MC; Hegyesi H; Igaz P; Polgár A; Toth S; Falus A
    Immunol Lett; 2002 Jun; 82(1-2):79-84. PubMed ID: 12008038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
    Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
    Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
    Hooper WC; Phillips DJ; Evatt BL
    Thromb Haemost; 1997 May; 77(5):1014-9. PubMed ID: 9184420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage.
    Thabard W; Barillé S; Collette M; Harousseau JL; Rapp MJ; Bataille R; Amiot M
    Clin Cancer Res; 1999 Oct; 5(10):2693-7. PubMed ID: 10537331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
    Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP
    Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
    Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
    Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
    Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
    Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.
    Haselmann J; Goppelt-Struebe M
    Cytokine; 1997 Mar; 9(3):199-205. PubMed ID: 9126708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.
    Horiuchi S; Koyanagi Y; Zhou Y; Miyamoto H; Tanaka Y; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Eur J Immunol; 1994 Aug; 24(8):1945-8. PubMed ID: 8056053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.